BST and IGTP are advancing the use of the particles that cells use to communicate as revolutionary therapies for the future
Researchers from BST, IGTP and Biosfer Teslab have demonstrated the potential of Nuclear Magnetic Resonance to monitor and optimise the manufacture of extracellular vesicles, one of the most promising therapeutic platforms in regenerative medicine. The findings, published in the Journal of Extracellular Vesicles, could help facilitate the development and scale-up of these therapies.